P36 Serum immunoglobulin levels and risk of serious infections in the pivotal phase III trials of ocrelizumab in multiple sclerosis and their open-label extensions. Issue 4 (April 2020)

Record Type:
Journal Article
Title:
P36 Serum immunoglobulin levels and risk of serious infections in the pivotal phase III trials of ocrelizumab in multiple sclerosis and their open-label extensions. Issue 4 (April 2020)
Main Title:
P36 Serum immunoglobulin levels and risk of serious infections in the pivotal phase III trials of ocrelizumab in multiple sclerosis and their open-label extensions
Authors:
Derfuss, T.
Weber, M.
Hughes, R.
Eggebrecht, J.
Wang, Q.
Sauter, A.
Koendgen, H.
Hauser, S.
Bar-Or, A.
Hartung, H.P.
Abstract:
Is Part Of:
Clinical neurophysiology. Volume 131:Issue 4(2020:Apr.)
Journal:
Clinical neurophysiology
Issue:
Volume 131:Issue 4(2020:Apr.)
Issue Display:
Volume 131, Issue 4 (2020)
Year:
2020
Volume:
131
Issue:
4
Issue Sort Value:
2020-0131-0004-0000
Page Start:
e196
Page End:
Publication Date:
2020-04
Subjects:
Neurophysiology -- Periodicals
Electroencephalography -- Periodicals
Electromyography -- Periodicals
Neurology -- Periodicals
612.8
Journal URLs:
http://www.sciencedirect.com/science/journal/13882457 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.clinph.2019.12.042 ↗
Languages:
English
ISSNs:
1388-2457
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3286.310645
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
13495.xml